Molson Coors’ smaller Milwaukee brewery, once a prized hub for production of craft beer, sits idle. Will anyone tap into its potential?
Molson Coors reports a year of progress; Vion Food Group to sell cattle marketing operations in Neumünster; Nestlé Purina ...
Piper Sandler analyst Michael Lavery maintained a Hold rating on Molson Coors (TAP – Research Report) today and set a price target of $67.00.
Molson Coors will assume exclusive commercialization rights to the company's Fever-Tree lineup of tonics, ginger beers and ...
The medical-imaging company issues solid guidance for 2025.
Roth MKM analyst Bill Kirk reiterated a Buy rating on Molson Coors (TAP – Research Report) today and set a price target of $75.00. The ...
Beer company Molson Coors (NYSE:TAP) reported Q4 CY2024 results , but sales fell by 2% year on year to $2.74 billion. Its non ...
Molson Coors beat fourth-quarter sales and profit estimates on Thursday, helped by recovering demand for its beer brands ...
The company also provided a full-year earnings outlook that guided for further growth, and was above Wall Street forecasts.
Looking ahead, Molson Coors ( NYSE: TAP) expects 2025 sales to rise at a low single-digit rate on a constant currency basis.
With Fevertree still priced at growth stock valuations, it pays to be cautious.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback